blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2134737

EP2134737 - FUNCTIONAL NUCLEIC ACIDS FOR BIOLOGICAL SEQUESTRATION [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  21.12.2012
Database last updated on 16.11.2024
Most recent event   Tooltip21.12.2012Application deemed to be withdrawnpublished on 23.01.2013  [2013/04]
Applicant(s)For all designated states
Biotex, Inc.
8058 El Rio
Houston, TX 77054 / US
[2009/52]
Inventor(s)01 / JACKSON, George, William
8058 El Rio Street
Houston, TX 77054 / US
02 / MCNICHOLS, Roger, Joseph
3626 Hugginsway Street
Pearland, tx 77584 / US
 [2009/52]
Representative(s)Carpintero Lopez, Francisco
Herrero & Asociados, S.L.
Agustín de Foxá, 4-10
28036 Madrid / ES
[N/P]
Former [2009/52]Carpintero Lopez, Francisco
Herrero & Asociados, S.L. Alcalá 35
28014 Madrid / ES
Application number, filing date08731736.807.03.2008
[2009/52]
WO2008US56303
Priority number, dateUS20070905792P08.03.2007         Original published format: US 905792 P
[2009/52]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2008109864
Date:12.09.2008
Language:EN
[2008/37]
Type: A2 Application without search report 
No.:EP2134737
Date:23.12.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 12.09.2008 takes the place of the publication of the European patent application.
[2009/52]
Search report(s)International search report - published on:US18.12.2008
(Supplementary) European search report - dispatched on:EP14.07.2010
ClassificationIPC:C07H21/02, C07H21/04, A01N63/00, A01N65/00, C12Q1/00, C12N5/00, C12N5/02
[2009/52]
CPC:
C12N15/1048 (EP,US); C12N15/63 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/52]
TitleGerman:FUNKTIONELLE NUKLEINSÄURE ZUR BIOLOGISCHEN SEQUESTRIERUNG[2009/52]
English:FUNCTIONAL NUCLEIC ACIDS FOR BIOLOGICAL SEQUESTRATION[2009/52]
French:ACIDES NUCLÉIQUES FONCTIONNELS POUR SÉQUESTRATION BIOLOGIQUE[2009/52]
Entry into regional phase01.09.2009National basic fee paid 
01.09.2009Search fee paid 
01.09.2009Designation fee(s) paid 
01.09.2009Examination fee paid 
Examination procedure01.09.2009Examination requested  [2009/52]
11.02.2011Amendment by applicant (claims and/or description)
11.07.2011Despatch of a communication from the examining division (Time limit: M04)
11.11.2011Reply to a communication from the examining division
03.02.2012Despatch of a communication from the examining division (Time limit: M06)
14.08.2012Application deemed to be withdrawn, date of legal effect  [2013/04]
19.09.2012Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2013/04]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  11.07.2011
Fees paidRenewal fee
09.08.2010Renewal fee patent year 03
21.03.2011Renewal fee patent year 04
23.02.2012Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
31.03.201003   M06   Fee paid on   09.08.2010
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XY]  - COTTEN M ET AL, "RIBOZYME MEDIATED DESTRUCTION OF RNA IN VIVO", EMBO JOURNAL, OXFORD UNIVERSITY PRESS, SURREY, GB, (19891201), vol. 8, no. 12, ISSN 0261-4189, pages 3861 - 3866, XP000616603 [X] 1-8 * page 3861, column l, paragraph 2 - page 3861, column r, paragraph 4; figure 1 * * page 2864, column l, paragraph 1 - page 3864, column r, paragraph 1 * * page 3866, column l, paragraphs 1-4 * [Y] 9-15
 [XY]  - MEDINA M F ET AL, "Design, characterization and testing of tRNA3Lys-based hammerhead ribozymes", NUCLEIC ACIDS RESEARCH, OXFORD UNIVERSITY PRESS, SURREY, GB, (19990401), vol. 27, no. 7, doi:10.1093/NAR/27.7.1698, ISSN 0305-1048, pages 1698 - 1708, XP002408106 [X] 1-8 * page 1699, column l, paragraphs 2,3 * * page 1700, column r, paragraph 5; figures 1,2 * * page 1702 * * page 1704, column r, paragraph 3 - page 1705, column r, paragraph 2; figure 8 * * page 1707, column l, paragraph l * [Y] 9-15

DOI:   http://dx.doi.org/10.1093/nar/27.7.1698
 [X]  - JIANG JIAN-DONG ET AL, "Construction of multifunctional genetically engineered pesticides-degrading bacteria by homologous recombination", MEDLINE, US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US, (200511), Database accession no. NLM16468341, XP002588135 [X] 9-11 * abstract *
    [ ] - SHENG WU GONG CHENG XUE BAO = CHINESE JOURNAL OF BIOTECHNOLOGY, (200511), vol. 21, no. 6, ISSN 1000-3061, pages 884 - 891
International search[Y]US2003219888  (SEGALL ANCA M [US], et al);
 [Y]US2005074865  (AFEYAN NOUBAR B [US], et al);
 [A]US2006057573  (GOLD LARRY [US], et al)
 [Y]  - LIM ET AL., "Current and developing technologies for monitoring agents of bioterrorism and biowarfare", CLINICAL MICROBIOLOGY REVIEWS, (200510), vol. 18, no. 4, pages 583 - 607, XP008116010

DOI:   http://dx.doi.org/10.1128/CMR.18.4.583-607.2005
 [X]  - THOMPSON J.D., "Strategies to express structural and catalytic RNAs in mammalian cells", METHODS IN ENZYMOLOGY, (1999), vol. 306, pages 241 - 260, XP001026501

DOI:   http://dx.doi.org/10.1016/S0076-6879(99)06016-4
Examination   - D'SOUZA LISA M ET AL, "Small RNA sequences are readily stabilized by inclusion in a carrier rRNA.", BIOTECHNOLOGY PROGRESS, (200305), vol. 19, no. 3, ISSN 8756-7938, pages 734 - 738
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.